NATURE’S SUNSHINE PRODUCTS, INC. Repayments of Long-Term Debt
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Repayments of Long-Term Debt of $397.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2021-05-06
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of long-term debt for the quarter ending 2021-03-31 was $397.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of long-term debt for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of long-term debt for the quarter ending 2019-03-31 was $1.52M, a 72.20% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of long-term debt for the quarter ending 2018-03-31 was $5.46M.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of long-term debt for fiscal 2018 was $81.50M, a 1257.70% increase from fiscal 2017.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of long-term debt for fiscal 2017 was $6.00M.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of long-term debt for fiscal 2016 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. repayments of long-term debt for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2021-03-31 | $397.00K 10-Q · filed 2021-05-06 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | |||
| 2019-03-31 | $1.52M 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | $81.50M 10-K · filed 2019-03-08 | |||
| 2018-03-31 | $5.46M 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $6.00M 10-K · filed 2019-03-08 | |||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-08 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-16 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $10.57M derived: sum of 2 quarters · filed 2017-03-14 | $11.42M derived: sum of 3 quarters · filed 2017-03-14 | $12.27M 10-K · filed 2017-03-14 |
| 2014-09-30 | $10.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $11.42M derived: sum of 2 quarters · filed 2015-11-06 | $12.27M 10-Q · filed 2015-11-06 | $13.11M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $848.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $1.70M 10-Q · filed 2015-08-10 | $2.54M derived: sum of 3 quarters · filed 2016-03-14 | $3.66M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $847.00K 10-Q · filed 2015-05-11 | $1.69M derived: sum of 2 quarters · filed 2016-03-14 | $2.81M derived: sum of 3 quarters · filed 2016-03-14 | $3.37M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $844.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $1.96M derived: sum of 2 quarters · filed 2016-03-14 | $2.52M derived: sum of 3 quarters · filed 2016-03-14 | $3.35M 10-K · filed 2016-03-14 |
| 2013-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.68M derived: sum of 2 quarters · filed 2014-11-06 | $2.51M 10-Q · filed 2014-11-06 | $3.61M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | $557.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.39M 10-Q · filed 2014-08-07 | $2.50M derived: sum of 3 quarters · filed 2015-03-13 | $3.32M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | $834.00K 10-Q · filed 2014-05-08 | $1.94M derived: sum of 2 quarters · filed 2015-03-13 | $2.76M derived: sum of 3 quarters · filed 2015-03-13 | $3.59M derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $1.93M derived: sum of 2 quarters · filed 2015-03-13 | $2.75M derived: sum of 3 quarters · filed 2015-03-13 | $3.57M 10-K · filed 2015-03-13 |
| 2012-09-30 | $825.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $1.65M derived: sum of 2 quarters · filed 2013-11-08 | $2.46M 10-Q · filed 2013-11-08 | |
| 2012-06-30 | $824.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $1.64M 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $816.00K 10-Q · filed 2013-05-09 | |||
| 2011-12-31 | $810.00K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |